FDAnews
www.fdanews.com/articles/101827-innovex-to-promote-pharmamar-s-yondelis-cancer-treatment

Innovex to Promote PharmaMar's Yondelis Cancer Treatment

December 5, 2007
Innovex announced a services agreement with PharmaMar, a subsidiary of Zeltia SA, to recruit, train and deploy a specialized oncology sales team in Western Europe to promote Yondelis, PharmaMar’s treatment for soft tissue sarcoma. PharmaMar, which holds the marketing authorization, will be responsible for marketing the drug.
Earthtimes.org